MicroRNAs miR-221 and miR-222: a new level of regulation in aggressive breast cancer

MicroRNAs (miRNAs) are crucial in the initiation and progression of tumors. A recent study has reported that the miRNAs miR-221 and miR-222 are involved in the promotion of an aggressive basal-like phenotype in breast cancer, functioning downstream of the RAS pathway and triggering epithelial-to-mes...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Maitri Y, Calin, George A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Highlight
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3238182/
https://www.ncbi.nlm.nih.gov/pubmed/21888691
http://dx.doi.org/10.1186/gm272
_version_ 1782218955070373888
author Shah, Maitri Y
Calin, George A
author_facet Shah, Maitri Y
Calin, George A
author_sort Shah, Maitri Y
collection PubMed
description MicroRNAs (miRNAs) are crucial in the initiation and progression of tumors. A recent study has reported that the miRNAs miR-221 and miR-222 are involved in the promotion of an aggressive basal-like phenotype in breast cancer, functioning downstream of the RAS pathway and triggering epithelial-to-mesenchymal transition. These new insights into the roles of miR-221/222 in breast cancer metastasis, drug resistance and RAS pathways could potentially have applications in medical practice.
format Online
Article
Text
id pubmed-3238182
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32381822011-12-16 MicroRNAs miR-221 and miR-222: a new level of regulation in aggressive breast cancer Shah, Maitri Y Calin, George A Genome Med Research Highlight MicroRNAs (miRNAs) are crucial in the initiation and progression of tumors. A recent study has reported that the miRNAs miR-221 and miR-222 are involved in the promotion of an aggressive basal-like phenotype in breast cancer, functioning downstream of the RAS pathway and triggering epithelial-to-mesenchymal transition. These new insights into the roles of miR-221/222 in breast cancer metastasis, drug resistance and RAS pathways could potentially have applications in medical practice. BioMed Central 2011-08-31 /pmc/articles/PMC3238182/ /pubmed/21888691 http://dx.doi.org/10.1186/gm272 Text en Copyright ©2011 BioMed Central Ltd.
spellingShingle Research Highlight
Shah, Maitri Y
Calin, George A
MicroRNAs miR-221 and miR-222: a new level of regulation in aggressive breast cancer
title MicroRNAs miR-221 and miR-222: a new level of regulation in aggressive breast cancer
title_full MicroRNAs miR-221 and miR-222: a new level of regulation in aggressive breast cancer
title_fullStr MicroRNAs miR-221 and miR-222: a new level of regulation in aggressive breast cancer
title_full_unstemmed MicroRNAs miR-221 and miR-222: a new level of regulation in aggressive breast cancer
title_short MicroRNAs miR-221 and miR-222: a new level of regulation in aggressive breast cancer
title_sort micrornas mir-221 and mir-222: a new level of regulation in aggressive breast cancer
topic Research Highlight
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3238182/
https://www.ncbi.nlm.nih.gov/pubmed/21888691
http://dx.doi.org/10.1186/gm272
work_keys_str_mv AT shahmaitriy micrornasmir221andmir222anewlevelofregulationinaggressivebreastcancer
AT calingeorgea micrornasmir221andmir222anewlevelofregulationinaggressivebreastcancer

Ejemplares similares